Primary follicular lymphoma of the cervix uteri: A review

Annals of Hematology

Volumn 86, Issue 9, 2007, Pages 623-630

  Korcum, Aylin Fidan ^a   Karadogan, Ihsan ^a   Aksu, Gamze ^a   Aralasmak, Ayse ^a   Erdogan, Gulgun ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Follicular; Primary cervix lymphoma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; AGED; BACKACHE; BONE MARROW BIOPSY; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CASE REPORT; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GRANULOCYTOPENIA; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPANICOLAOU TEST; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; TRANSVAGINAL ECHOGRAPHY; TUMOR CLASSIFICATION; UTERINE CERVIX BIOPSY; UTERINE CERVIX TUMOR; VAGINA BLEEDING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CERVIX UTERI; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, FOLLICULAR; RECURRENCE; UTERINE CERVICAL NEOPLASMS;

EID: 34547641217     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-007-0328-0     Document Type: Review

References (61)

1. Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29(1):252-260
2. Charlton I, Karnei RF, King FM, Norris HJ (1974) Primary malignant reticulendothelial disease involving the vagina, cervix and corpus uteri. Obstet Gynecol 44:735-748
3. Vang R, Medeiros LJ, Ha CS, Deavers M (2000) Non-Hodgkin's lymphomas involving the uterus: A clinicopathologic analysis of 26 cases. Mod Pathol 13:19-28
4. Harris NL, Scully RE (1984) Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. Cancer 53:2530-2545
5. Muntz HG, Ferry JA, Flynn D, Fuller AF Jr, Tarraza HM (1991) Stage IE primary malignant lymphomas of the uterine cervix. Cancer 68(9):2023-2032
6. Stroh EL, Besa PC, Cox JD, Fuller LM, Cabanillas FF (1995) Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer 75:2392-2399
7. Grace A, O'Connell N, Byrne P, Prendiville W, O'Donnell R, Royston D, Walsh CB, Leader M, Kay E (1999) Malignant lymphoma of the cervix. An unusual presentation and a rare disease. Eur J Gynaecol Oncol 20(1):26-28
8. Baxter NP, Lane G, Swift S (2003) Primary malignant follicular lymphoma of the cervix: A rare cause of postmenopausal bleeding. BJOG 110(3):337-338
9. Bode MK, Tikkakoski T, Johansson J, Johansson K, Kariniemi J, Apaja-Sarkkinen M, Tuominen H (2002) Lymphoma of the cervix. Acta Radiol 43(4):431-432
10. Hariprasad R, Kumar L, Bhatla N, Kukreja M, Papaiah S (2006) Primary uterine lymphoma: Report of 2 cases and review of literature. Am J Obst Gynecol 195:308-313
11. Lee KM, Seah ES, Sethi VK (1998) Primary non-Hodgkin's lymphoma of the uterine cervix: Case report of long-term survival of two patients treated with surgery and radiotherapy. Austral Radiol 42:126-127
12. Van Renterghem N, De Paepe P, Van den Broecke R, Bourgain C, Serreyn R (2005) Primary lymphoma of the cervix uteri: A diagnostic challenge. Report of two cases and review of the literature. Eur J Gynaecol Oncol 26(1):36-38
13. Thyagarajan MS, Dobson MJ, Biswas A (2004) Appearance of uterine cervical lymphoma on MRI: A case report and review of the literature. Br J Radiol 77:512-515
14. Kuo HC, Chou CY, Chang CH, Liu MT, Tzeng CC, Huang KE (1994) Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy. Gynecol Oncol 52(3):408-410
15. Szantho A, Balega JJ, Csapo Z, Sreter LL, Matolcsy A, Papp Z (2003) Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: Case report. Gynecol Oncol 89(1):171-174
16. Perren T, Farrant M, McCarthy K, Harper P, Wiltshaw E (1992) Lymphomas of the cervix and upper vagina: A report of five cases and a review of the literature. Gynecol Oncol 44(1):87-95
17. Frey NV, Svoboda J, Andreadis C, Tsai DE, Schuster SJ, Elstrom R, Rubin SC, Nasta SD (2006) Primary lymphomas of the cervix and uterus: The University of Pennsylvania's experience and a review of the literature. Leuk Lymphoma 47(9):1894-1901
18. Cohn DE, Resnick KE, Eaton LA, deHart J, Zanagnolo V (2007) Non-Hodgkin's lymphoma mimicking gynecological malignancies of the vagina and cervix: A report of four cases. Int J Gynecol Cancer 17(1):274-279
19. Vang R, Medeiros LJ, Fuller GN, Sarris AH, Deavers M (2001) Non-Hodgkin's lymphoma involving the gynecologic tract: A review of 88 cases. Adv Anat Pathol 8:200-217
20. Montoto S, Lopez-Guillermo A, Altes A, Perea G, Ferrer A, Camos M, Villela L, Bosch F, Esteve J, Cervantes F, Blade J, Nomdedeu B, Campo E, Sierra J, Montserrat E (2004) Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol 15(10):1484-1489
21. Pham DC, Guthrie TH, Ndubisi B (2003) HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma. Gynecol Oncol 90(1):204-206
22. Kendrick JE 4th, Straughn JM Jr (2005) Two cases of non-Hodgkin's lymphoma presenting as primary gynecologic malignancies. Gynecol Oncol 98(3):490-492
23. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31(11):1860-1861
24. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 162-167
25. Aozasa K, Saeki K, Ohsawa M, Horiuchi K, Mishima K, Tsujimoto M (1993) Malignant lymphoma of the uterus. Report of seven cases with immunohistochemical study. Cancer 72(6):1959-1964
26. Trenhaile TR, Killackey MA (2001) Primary pelvic non-Hodgkin's lymphoma. Obstet Gynecol 97(5):717-720
27. Makarewicz R, Kuzminska A (1995) Non-Hodgkin's lymphoma of the uterine cervix: A report of three patients. Clin Oncol (R Coll Radiol) 7(3):198-199
28. Komaki R, Cox JD, Hansen RM, Gunn WG, Greenberg M (1984) Malignant lymphoma of the uterine cervix. Cancer 54(8):1699-1704
29. Awwad JT, Khalil AM, Shamseddine AI, Mufarrij AA (1994) Primary malignant lymphoma of the uterine cervix: Is radiotherapy the best therapeutic choice for stage IE? Gynecol Oncol 52(1):91-93
30. Tunca JC, Reddi PR, Shah SH, Slack ST (1979) Malignant non-Hodgkin's-type lymphoma of the cervix uteri occurring during pregnancy. Gynecol Oncol 7:385-393
31. Yokoyama Y,Sato S, Xiao YH, Tanaka K, Maruyama H, Saito Y (2001) Primary non-Hodgkin's lymphoma of the uterine cervix. Arch Gynecol Obstet 265:108-111
32. Strang P, Sorbe B, Sundstrom C (1988) Primary aneuploid lymphoma of the uterine cervix: A case report. Gynecol Oncol 30(2):302-305
33. Khoury GG, Robinson A (1989) Lymphoma of uterine cervix. Eur J Surg Oncol 15(1):65-67
34. Heredia F, Bravo M, Pierotic M, Majlis A, Carmona L (2005) Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix. Gynecol Oncol 97(1):285-287
35. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328(14):1002-1006
36. Chandy L, Kumar L, Dawar R (1998) Non-Hodgkin's lymphoma presenting as a primary lesion in uterine cervix: Case report. J Obstet Gynaecol Res 24:183-187
37. Chan JK, Loizzi V, Magistris A, Hunter MI, Rutgers J, DiSaia PJ, Berman ML (2005) Clinicopathologic features of six cases of primary cervical lymphoma. Am J Obstet Gynecol 193(3 Pt 1):866-872
38. Castaldo TW, Ballon SC, Lagasse LD, Petrilli ES (1979) Reticuloendothelial neoplasia of the female genital tract. Obstet Gynecol 54(2):167-170
39. Papadopoulos AJ, Pambakian H, Devaja O, Raju KS (1996) High grade non-Hodgkin's stage IEB primary malignant lymphoma of the cervix and upper vagina. A case report. Eur J Gynaecol Oncol 17(6):484-486
40. Mansouri H, Kebdani T, Hassouni K, El Gueddari B (2001) Unusual locations for lymphomas. Case 1. Intermediate-grade lymphoma of the cervix. J Clin Oncol 19(11):2959-2960
41. Kahlifa M, Buckstein R, Perez-Ordonez B (2003) Sarcomatoid variant of B-cell lymphoma of the uterine cervix. Int J Gynecol Pathol 22(3):289-293
42. Cantu de Leon D, Perez Montiel D, Chanona Vilchis J (2006) Primary malignant lymphoma of uterine cervix. Int J Gynecol Cancer 16(2):923-927
43. Montoto S, Lopez-Guillermo A, Altes A, Perea G, Ferrer A, Camos M, Villela L, Bosch F, Esteve J, Cervantes F, Blade J, Nomdedeu B, Campo E, Sierra J, Montserrat E (2004) Predictive value of follicular lymphoma international prognostic index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol 15(10):1484-1489
44. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, Anderson L, Linch DC (1994) Clinical stage 1 non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 69(6):1088-1093
45. Kelsey SM, Newland AC, Hudson GV, Jelliffe AM (1994) A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkin's lymphoma. Med Oncol 11(1):19-25
46. MacManus MP, Seymour JF (2001) Management of localized low-grade follicular lymphomas. Australas Radiol 45:326-334
47. Gospodarowicz MK, Bush RS, Brown TC, Chua T (1984) Prognostic factors in nodular lymphomas: A multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 10:489-497
48. Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez AJ (2004) Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 22:4711-4716
49. McLaughlin P, Fuller LM, Velasquez WS, Sullivan-Halley JA, Butler JJ, Cabanillas F (1986) Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer 58(8):1596-1602
50. Morel P, Dupriez B, Plantier-Colcher I, Gosselin B, Declercq C, Pollet JP, Bauters F (1993) Long-term outcome of follicular low-grade lymphoma. A report of 91 patients. Ann Hematol 66(6):303-308
51. Carde P, Burgers JM, van Glabbeke M, Hayat M, Cosset JM, Somers R, Sizoo W, Qasim MM, Lefur R, Abbatucci JS, et al.(1984) Combined radiotherapy-chemotherapy for early stages non-Hodgkin's lymphoma: The 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 2(4):301-312
52. Nissen NI, Ersboll J, Hansen HS, Walbom-Jorgensen S, Pedersen-Bjergaard J, Hansen MM, Rygard J (1983) A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1;52(1):1-7
53. Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ (1993) Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study. Cancer 71(7):2342-2350
54. Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P (2003) Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol 21(11):2115-2122
55. Boye J, Elter T, Engert A (2003) An overview of the current clinical use of anti-CD20 monoclonal antibody rituximab. Ann Oncol 14:520-535
56. McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program. J Clin Oncol 16(8):2825-2833
57. Foran JM, Gupta RK, Cunningham D, Popescu RA, Goldstone AH, Sweetenham JW, Pettengell R, Johnson PW, Bessell E, Hancock B, Summers K, Hughes J, Rohatiner AZ, Lister TA (2000) A UK multicentre phase II study of Rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response. Br J Haematol 109(1):81-88
58. Colombat P, Salles G, Brousse N, Eftekhari P, Soubeyran P, Delwail V, Deconinck E, Haioun C, Foussard C, Sebban C, Stamatoullas A, Milpied N, Boue F, Taillan B, Lederlin P, Najman A, Thieblemont C, Montestruc F, Mathieu-Boue A, Benzohra A, Solal-Celigny P (2001) Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation. Blood 97(1):101-106
59. Igarashi T, Kobayashi Y, Ogura M, Kinoshita T, Ohtsu T, Sasaki Y, Morishima Y, Murate T, Kasai M, Uike N, Taniwaki M, Kano Y, Ohnishi K, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K (2002) IDEC-C2B8 Study Group in Japan. Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: A Japanese phase II study. Ann Oncol 13(6):928-943
60. Forstpointner R, Dreyling M, Repp R, Hermann S, Hanel A, Metzner B, Pott C, Hartmann F, Rothmann F, Rohrberg R, Bock HP, Wandt H, Unterhalt M, Hiddemann W, German Low-Grade Lymphoma Study Group (2004) The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood 104(10):3064-3071
61. Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH (2005) Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol 23(4):694-704